Home NDC 72974-120 Orgovyx
Product NDC 72974-120
11-digit product format 729740120
Labeler code 72974
Product ID 72974-120_3090b0d4-bc5f-4d32-91d9-bf63a0ce3a84
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name relugolix
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Sumitomo Pharma America, Inc.
Application NDA214621
Marketing category NDA
Marketing start 2020-12-18
Substance RELUGOLIX
Active strength 120 mg/1
Pharmacologic classes Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 34 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 72974-120-04 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 unfinished product product 1d862106b807…00c93037cd84…2025-08-26 23:59 UTC · source 2025-08-26 unfinished package package 72974-120-04 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 unfinished product product 390b4c401c3f…2c692c2daee3…2025-05-15 14:59 UTC · source 2025-05-14 unfinished package package 72974-120-04 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 unfinished product product e30019b0c005…a3f0b14938b7…2025-04-01 07:37 UTC · source 2025-03-31 unfinished package package 72974-120-04 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 unfinished product product bbbc9f937eca…946b9c97cf81…2025-03-01 13:19 UTC · source 2025-02-28 unfinished package package 72974-120-04 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 unfinished product product f268b84574a6…26285f5ac5df…2025-02-27 05:24 UTC · source 2025-02-26 unfinished package package 72974-120-04 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 unfinished product product f764e8902f78…92046438deef…2025-02-01 13:13 UTC · source 2025-01-31 unfinished package package 72974-120-04 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 unfinished product product 68b1e3bced9e…98a755eb8bc6…2025-01-20 13:05 UTC · source 2025-01-17 unfinished package package 72974-120-04 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 unfinished product product 05c55d027831…ca05dca9dc4c…2024-11-29 20:42 UTC · source 2024-11-29 unfinished package package 72974-120-04 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 unfinished product product 48b4f40e6753…c7c7a00d2afa…2024-11-09 02:36 UTC · source 2024-11-08 unfinished package package 72974-120-04 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 unfinished product product 27f29a85d7e4…1372111e901f…2024-10-09 02:27 UTC · source 2024-10-08 unfinished package package 72974-120-04 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 unfinished product product 8d62ce987f31…9fe9ef23e30d…2024-07-10 04:00 UTC · source 2024-07-09 unfinished package package 72974-120-04 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished product product d1e113ab4d42…063ee3eb0a1d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished package package 72974-120-04 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 unfinished product product 50b4072663b7…eae3003ed65e…2024-05-15 03:51 UTC · source 2024-05-14 unfinished package package 72974-120-04 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 unfinished product product 906f6e251498…bf70b80e44f0…2022-04-09 23:13 UTC · source 2022-04-08 unfinished package package 72974-120-04 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 unfinished product product 6db9cb8d1e19…3449e1ec5b70…2021-12-27 23:28 UTC · source 2021-12-27 unfinished package package 72974-120-04 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 unfinished product product 8fc7167e32ce…e96bbc724034…2021-02-18 23:40 UTC · source 2021-02-18 unfinished package package 72974-120-04 8fc7167e32ce…e96bbc724034…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214621-001 ORGOVYX RELUGOLIX 120MG TABLET / ORAL RLD, RS 2020-12-18
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214621-001 8058280 2026-01-28 Drug substance, Drug product 2021-01-14 N214621-001 7300935 2029-01-28 Drug substance 2021-01-14 N214621-001 11795178 2033-09-27 Drug substance, Drug product 2023-10-25 N214621-001 12325714 2033-09-27 Drug substance, Drug product 2025-06-11 N214621-001 10350170 2036-02-25 Drug product 2021-01-14 N214621-001 10449191 2037-09-29 U-3020 2021-01-14 N214621-001 10786501 2037-09-29 U-3020 2021-01-14 N214621-001 11583526 2037-09-29 U-3020 2023-03-16 N214621-001 12097198 2037-09-29 U-3020 2024-09-25 N214621-001 12144809 2037-09-29 U-4035 2024-11-21 N214621-001 12336990 2037-09-29 U-3020 2025-06-25 N214621-001 12629370 2037-09-29 U-3020 2026-06-09
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 c2088c7a36db…2026-09-14 22:38:34 2026-08 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 5aa47cf7b7d7…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214621-001 ORGOVYX 120MG TABLET / ORAL RLD, RS 2020-12-18 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 9 · 321 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N214621-001 8058280 2026-01-28 Drug substance, Drug product 2021-01-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 7300935 2029-01-28 Drug substance 2021-01-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 11795178 2033-09-27 Drug substance, Drug product 2023-10-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 12325714 2033-09-27 Drug substance, Drug product 2025-06-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 10350170 2036-02-25 Drug product 2021-01-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 10449191 2037-09-29 U-3020 2021-01-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 10786501 2037-09-29 U-3020 2021-01-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 11583526 2037-09-29 U-3020 2023-03-16 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 12097198 2037-09-29 U-3020 2024-09-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 12144809 2037-09-29 U-4035 2024-11-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 12336990 2037-09-29 U-3020 2025-06-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214621-001 12629370 2037-09-29 U-3020 2026-06-09 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N214621-001 8058280 2026-01-28 Drug substance, Drug product 2021-01-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 7300935 2029-01-28 Drug substance 2021-01-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 11795178 2033-09-27 Drug substance, Drug product 2023-10-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 12325714 2033-09-27 Drug substance, Drug product 2025-06-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 10350170 2036-02-25 Drug product 2021-01-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 10449191 2037-09-29 U-3020 2021-01-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 10786501 2037-09-29 U-3020 2021-01-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 11583526 2037-09-29 U-3020 2023-03-16 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 12097198 2037-09-29 U-3020 2024-09-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 12144809 2037-09-29 U-4035 2024-11-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 12336990 2037-09-29 U-3020 2025-06-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214621-001 12629370 2037-09-29 U-3020 2026-06-09 c2088c7a36db…2026-09-14 22:38:34 2026-08 N214621-001 8058280 2026-01-28 Drug substance, Drug product 2021-01-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 7300935 2029-01-28 Drug substance 2021-01-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 11795178 2033-09-27 Drug substance, Drug product 2023-10-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 12325714 2033-09-27 Drug substance, Drug product 2025-06-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 10350170 2036-02-25 Drug product 2021-01-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 10449191 2037-09-29 U-3020 2021-01-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 10786501 2037-09-29 U-3020 2021-01-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 11583526 2037-09-29 U-3020 2023-03-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 12097198 2037-09-29 U-3020 2024-09-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 12144809 2037-09-29 U-4035 2024-11-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 12336990 2037-09-29 U-3020 2025-06-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214621-001 12629370 2037-09-29 U-3020 2026-06-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214621-001 8058280 2026-01-28 Drug substance, Drug product 2021-01-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214621-001 7300935 2029-01-28 Drug substance 2021-01-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214621-001 11795178 2033-09-27 Drug substance, Drug product 2023-10-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214621-001 12325714 2033-09-27 Drug substance, Drug product 2025-06-11 caaa826d4ba7…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Orgovyx
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RELUGOLIX 120 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination P76B05O5V6 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2472783 Internal RxNorm lookup 2472789 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72974-120-01 Orgovyx 30 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 30 12 72974-120-95 Orgovyx 16 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 16 12 72974-120-97 Orgovyx 30 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 30 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72974-120 ORGOVYX (RELUGOLIX) TABLET, FILM COATED [SUMITOMO PHARMA AMERICA, INC.] 11 Current NDC, Legacy NDC, 3 package rows 20241031_077a92f6-9f1b-479a-87c7-c92b5db6aa9c.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 72974-120-01 72974012001 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01) 2020-12-18 0000-00-00 No No Current 72974-120-95 72974012095 16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95) 2023-01-27 Yes No Current 72974-120-97 72974012097 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97) 2021-10-21 0000-00-00 Yes No Current